Coronavirus channel feed

Lil­ly's Covid-19 part­ner Ab­Cellera is tak­ing a new an­ti­body in­to the clin­ic in the hopes it can tack­le all vari­ants

5 years ago

Covid-19 roundup: No­vavax plots EU vac­cine ship­ments by end of year — re­port; Pfiz­er pledges med­i­cines, equip­ment to In­dia

5 years ago

A mus­cled up Mod­er­na fi­nal­ly joins the CO­V­AX crew, pledg­ing 500M dos­es for low-in­come coun­tries

5 years ago
Deals

As­traZeneca's non-prof­it vac­cine is, for now, cost­ing them mon­ey

5 years ago
Pharma

Emer­gent reshuf­fles its man­u­fac­tur­ing brain trust as CEO sends mixed mes­sages around Covid-19 vac­cine de­ba­cle

5 years ago
Manufacturing

Stan­ley Er­ck bagged $48M in pay as he guid­ed No­vavax on a re­mark­able turn­around in the hunt for a Covid-19 vac­cine

5 years ago
People

Covid-19 roundup: As­traZeneca strug­gling to com­pile da­ta for FDA OK — re­port

5 years ago

Covid-19 man­u­fac­tur­ing roundup: Catal­ent adds freez­er part­ner for vac­cine pro­duc­tion push; In need of vol­un­teers, Lon­za turns to food work­ers

5 years ago
Manufacturing

Covid-19 roundup: Atea Phar­ma­ceu­ti­cals launch­es an­tivi­ral in­to PhI­II tri­al; Cell­tri­on's an­ti­body shows promise against vari­ant

5 years ago

Mod­er­na tur­bocharges its sup­ply chain, up­ping com­mit­ment to 3B dos­es per year for a fu­ture where boost­ers are like­ly

5 years ago
Outsourcing
Manufacturing

US ups fund­ing for Mod­er­na Covid-19 vac­cine as to­tal nears $6B

5 years ago
Financing

Covid-19 roundup: Eu­ro­pean Com­mis­sion's le­gal bat­tle against As­traZeneca be­gins; Kaza­khstan gives green light to do­mes­tic vac­cine

5 years ago

Covid-19 roundup: Gilead aims remde­sivir to­ward help­ing In­dia out­break; Mer­ck pairs with 5 In­di­an gener­ics man­u­fac­tur­ers for mol­nupi­ravir

5 years ago

Covid-19 roundup: Eu­ro­pean Com­mis­sion sues As­traZeneca over vac­cine sup­plies; South Africa re­sumes J&J vac­cine tri­al

5 years ago

Sanofi lands 3rd Covid-19 vac­cine man­u­fac­tur­ing part­ner as it works to push for­ward its own jab

5 years ago
Manufacturing

J&J vac­ci­na­tions re­sume as FDA, CDC con­fi­dent in ben­e­fit-risk pro­file

5 years ago
FDA+

In­ovio's Covid-19 vac­cine stud­ies just hit a brick wall at the Pen­ta­gon. Are oth­er hope­fuls in trou­ble?

5 years ago

Covid-19 roundup: EMA ups Pfiz­er, Mod­er­na vac­cine man­u­fac­tur­ing ca­pa­bil­i­ties amid short­age

5 years ago

Covid-19 man­u­fac­tur­ing roundup: Mary­land looks to grow biotech ca­pac­i­ty with $400M check; Rus­sia lands sec­ond Sput­nik V part­ner this week

5 years ago
Manufacturing

In a sup­ply chain short­age workaround, Aus­trali­a's Vic­to­ria state aims to build its own mR­NA fa­cil­i­ty

5 years ago
Manufacturing

Covid-19 roundup: Eu­ro­pean Com­mis­sion pre­pares to sue for As­traZeneca dos­es — re­port; NIH adds poly­clon­al an­ti­body to AC­TIV-2 tri­al

5 years ago

As fears mount over J&J and As­traZeneca, No­vavax en­ters a shaky spot­light

5 years ago
In Focus

Covid-19 roundup: BioN­Tech ex­ec says new pro­duc­tion sites could be added to meet de­mand — re­port; Giv­ing up on the EC, Val­ne­va looks to in­di­vid­ual coun­tries for vac­cine sup­ply deals

5 years ago

Roche sees a slight dip in Q1 as biosim­i­lars keep bit­ing in­to block­buster on­col­o­gy tri­o's sales

5 years ago
Pharma
First page Previous page 28293031323334 Next page Last page
A service from the Financial Times